Your institution may have access to this item. Find your institution then sign in to continue.
Title
Re: Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido: North Central Cancer Treatment Group Protocol N02C3.
A letter to the editor is presented in response to the article "Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido: North Central Cancer Treatment Group Protocol N02C3," by D. L. Barton, D. B. Wender, and J. A. Sloan.